This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

2024 ASCO® Annual Meeting Insights Hub
V

ASCO® 2024 Insights: "Efficacy & Toxicity of 177Lu-PSMA-617 for mCRPC in a Real-World Setting - Results From the U.S. Expanded Access Program and Comparisons With Phase 3 VISION Data"

By 2024 ASCO® Annual Meeting Insights Hub FEATURING Vishnu Murthy
By 2024 ASCO® Annual Meeting Insights Hub FEATURING Vishnu Murthy
173 views
June 5, 2024

Chapters

Efficacy & Toxicity of Lutetium PSMA-617

00:00

Comparative Analysis & Study Limitations

04:13

0 Comments
Login to view comments. Click here to Login

2024 ASCO® Annual Meeting Insights Hub: GU Videos

21:54
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Prostate Cancer Take-Home Messages

Feat. E. Efstathiou
10:19
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Current Updates in RCC - Clinical Implicat…

Feat. K. Mittal
15:28
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Bladder and RCC Highlights"

Feat. K. Tawagi, N. Reizine
View All

Related Content

AUTOPLAY
Advanced Prostate Cancer Consensus Conference (APCCC)

APCCC 2026

Fri, Feb 27, 2026
International Urology Cancer Summit - IUCS

Second International Urology Cancer Summit

Fri, Sep 27, 2024
14:16
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Summary: "Important Prostate Cancer Take-Home Mes…

Feat. E. Efstathiou
16:05
Insights from 2024 ASCO® GU Annual Meeting

Recent GU Developments and Their Clinical Implications

Feat. T. Powles, B. Rini
20:41
2024 ASCO® Annual Meeting Insights Hub

Bladder Cancer Highlights From ASCO® 2024

Feat. G. Sonpavde
17:50
AdventHealth

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

Feat. G. Sonpavde
27:04
Fengting Yan

Cancer Screening Molecular Tools

11:56
Ana Aparicio

Aggressive Variant Prostate Cancer: Definition, Diagnosis, Treatment…

25:23
Houston Methodist

Whole-Body MRI: Past, Present, and Future

Feat. N. Gupta
29:25
Northwestern Medicine Oncology and Hematology

Hyperprogression in Cancer Treated With Immunotherapy

Feat. Y. Chae
09:14
Robert Dreicer

AUA Advanced Prostate Cancer Guidelines: 2023 Update

21:54
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Prostate Cancer Take-Home Messages

Feat. E. Efstathiou
34:26
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Prostate Cancer Highlights"

Feat. N. Reizine, K. Tawagi
03:05
Benjamin L. Maughan

Testosterone Suppression and Recovery in Patients With Advanced Pros…

05:18
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "PSMAddition - A Phase 3 Trial to Compare …

Feat. S. Tagawa
06:27
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Evaluation of Persistence and Adherence f…

Feat. J. Hafron
18:43
University of Miami Sylvester Comprehensive Cancer Center

Precision Therapies for Prostate Cancer

Feat. M. Bilusic
22:27
2024 ASCO® Annual Meeting Insights Hub

Developmental Therapeutics Highlights From ASCO® 2024

Feat. G. Sonpavde
17:33
Insights from AUA 2024 Annual Meeting

AUA 2024 Insights: "Manipulating the Androgen Axis - New Agents…

Feat. D. Jarrard
08:05
Total Health

Prostate Cancer Updates From ASCO® 2023

Feat. T. Zhang
10:19
University of Colorado Cancer Center

NCCN Guidelines Updates for the Treatment of Metastatic Urothelial C…

Feat. T. Flaig
11:39
Oncology Data Advisor

Recent Prostate Cancer Updates

Feat. U. Vaishampayan